| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.10. | Physitrack Q3 2025: Umsatz steigt, Aktie fällt deutlich | 1 | Investing.com Deutsch | ||
| 21.10. | Physitrack PLC - Interim Report: January - September 2025 | 275 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / October 21, 2025 / Physitrack PLC (STO:PTRK) - Fourth Consecutive Quarter of Resilient, Cash-Generative Growth, Marking Historical Positive Cash flow.Investor snapshotMetricQ3... ► Artikel lesen | |
| 21.10. | Physitrack PLC Q3 Sales Decline | 2 | RTTNews | ||
| 14.10. | Invitation to Physitrack PLC Q3 2025 Interim Report Webcast Conference | 169 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / October 14, 2025 / Physitrack PLC (STO:PTRK) - The global digital healthcare provider Physitrack PLC (PTRK) plans to publish its Q3 2025 interim report on October 21,... ► Artikel lesen | |
| 25.09. | Physitrack Plc Announces Deal with European Insurer to Launch Consumer-facing Self-management Product | 237 | ACCESS Newswire | Physitrack PLC (STO:PTRK) - First phase of agreement generates €55,000 of upfront and €24,000 annual recurring revenue, strengthens Physitrack's presence in direct to consumer offering. LONDON, UK /... ► Artikel lesen | |
| 03.09. | Physitrack PLC Adjusts its Financial Calendar - Earlier Publication of Q3 2025 Interim Report | 238 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / September 3, 2025 / Physitrack PLC (STO:PTRK) - Physitrack PLC has adjusted its previously communicated financial calendar for 2025. The date for publication of the Q3... ► Artikel lesen | |
| 28.08. | Physitrack PLC Announces Appointment of New Head of Sales, North America | 326 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / August 28, 2025 / Physitrack PLC (STO:PTRK) - Physitrack PLC today announced the appointment of Yanni Metaxas as its new Head of Sales for North America, effective 1 September... ► Artikel lesen | |
| 31.07. | Physitrack PLC: Physitrack Announces Commercial Partnership with Leading UK Rehabilitation Provider Pure Physiotherapy | 401 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / July 31, 2025 / Physitrack PLC (STO:PTRK) has entered into a commercial partnership with Pure Physiotherapy, one of the UK's leading providers of musculoskeletal (MSK)... ► Artikel lesen | |
| PHYSITRACK Aktie jetzt für 0€ handeln | |||||
| 24.07. | Physitrack PLC: Interim report: January - June 2025 | 269 | GlobeNewswire (Europe) | Operational discipline and innovation drive EUR 0.9m rebound, marking historical quarterly positive cash flow.
Investor snapshotMetricQ2 2025Q2 2024YoY ?Q1 2025QoQ ?Revenue (Pro Forma) EUR m3.53.36%3.6-1%Constant... ► Artikel lesen | |
| 17.07. | Invitation to Physitrack PLC Q2 2025 Interim Report Webcast Conference | 361 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / July 17, 2025 / Physitrack PLC (STO:PTRK) - The global digital healthcare provider Physitrack PLC (PTRK) plans to publish its Q2 2025 interim report on July 24, 2025,... ► Artikel lesen | |
| 14.07. | Physitrack PLC Adjusts its Financial Calendar - Earlier Publication of Q2 2025 Interim Report | 441 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / July 14, 2025 / Physitrack PLC (STO:PTRK) - Physitrack PLC has adjusted its previously communicated financial calendar for 2025. The date for publication of the Q2 2025... ► Artikel lesen | |
| 30.06. | Bulletin from Physitrack PLC's Annual General Meeting | 236 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / June 30, 2025 / Physitrack PLC (STO:PTRK) - At the Annual General Meeting (the AGM) of Physitrack PLC ("Physitrack" or the "Company"), on 27 June 2025, the following resolutions... ► Artikel lesen | |
| 23.05. | Physitrack Plc: Notice of Annual General Meeting | 333 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / May 23, 2025 / Physitrack PLC (STO:PTRK) - This Notice of Annual General Meeting is an important document and requires your immediate attention. If you are in any doubt... ► Artikel lesen | |
| 30.04. | Physitrack PLC: Interim Report: January - March 2025 | 286 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / April 30, 2025 / Physitrack PLC (STO:PTRK) - Driving Financially Robust Evolution through Streamlined Operations and High-Margin Innovations.Summary for the periodFirst... ► Artikel lesen | |
| 23.04. | Invitation to Physitrack PLC Q1 2025 Interim Report Webcast Conference | 297 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / April 23, 2025 / Physitrack PLC (STO:PTRK) - The global digital healthcare provider Physitrack PLC (PTRK) plans to publish its Q1 2025 interim report on April 30, 2025... ► Artikel lesen | |
| 07.04. | Physitrack PLC Adjusts its Financial Calendar - Earlier Publication of Interim Reports 2025 | 239 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / April 7, 2025 / Physitrack PLC (STO:PTRK) - Physitrack PLC has adjusted its previously communicated financial calendar for 2025. The date for publication of the Q1 interim... ► Artikel lesen | |
| 28.03. | Physitrack PLC Announces Publication of 2024 Audited Financial Statements | 482 | ACCESS Newswire | LONDON, UNITED KINGDOM / ACCESS Newswire / March 28, 2025 / Physitrack PLC (STO:PTRK) Solid Foundation for 2025: Strong Recurring Revenue and Positive Operating Cashflow Amid Strategic Pivot.Physitrack... ► Artikel lesen | |
| 28.03. | Physitrack Plc Divests German Wellness Subsidiary, annual saving of €150,000, EBITDA Margin Expansion to 30% in 2025 expected | 929 | ACCESS Newswire | LONDON, GB / ACCESS Newswire / March 28, 2025 / Physitrack PLC (STO:PTRK) has successfully finalised a management buyout (MBO) of its German wellness subsidiary, Wellnow, in a strategic move that aligns... ► Artikel lesen | |
| 21.03. | Physitrack PLC Announces CFO Maternity Leave and Interim Appointment | 381 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / March 21, 2025 / Physitrack PLC (STO:PTRK) announces that Chief Financial Officer Charlotte Goodwin will be going on maternity leave starting April 1, 2025. During her... ► Artikel lesen | |
| 07.03. | Physitrack Plc Wins Finnish County Tender, Securing €63,000 Deal with Potential to Exceed €200,000 | 346 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / March 7, 2025 / Physitrack PLC (STO:PTRK) has successfully secured a public tender with a Finnish county healthcare system, reinforcing its position as a trusted provider... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,290 | +2,42 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Siemens Healthineers, Deutsche Bank und Suss Microtec | © Foto: Daniel Karmann/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 10:00... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,340 | +1,97 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,560 | +1,32 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
17.11.2025 /... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 44,620 | +2,91 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hatCarl Zeiss Meditec auf "Overweight" mit einem Kursziel von 52 Euro belassen. Die Aktienkurse der europäischen Medizintechnik-Unternehmen... ► Artikel lesen | |
| GENEDX | 153,93 | +5,04 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| ALIGNMENT HEALTHCARE | 18,100 | +8,38 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| GERRESHEIMER | 24,020 | +1,95 % | EQS-News: Gerresheimer AG: Science Based Targets Initiative bestätigt CO2e Reduktionsziele | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit
Gerresheimer: Science Based Targets Initiative bestätigt CO2e Reduktionsziele
18.11.2025 / 10:02 CET/CEST
Für... ► Artikel lesen | |
| PROGYNY | 26,370 | +2,01 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| BRIGHTSPRING HEALTH SERVICES | 35,650 | +2,98 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| OTTOBOCK | 73,00 | +3,03 % | Ottobock-Aktie: DIESER deutsche Hidden-Champion macht Bock auf mehr | © Foto: Swen Pförtner - dpaDer Prothesenhersteller Ottobock blickt nach dem erfolgreichen Börsengang zuversichtlich in die Zukunft. Jetzt nehmen namhafte Analysten die Aktie unter die Lupe.Seit dem... ► Artikel lesen | |
| UNITEDHEALTH | 278,80 | +0,36 % | Wichtige Termine! LVMH, UnitedHealth, Meta, Strategy, Bitcoin im Check | Die Aktienmärkte haben eine schwache Handelswoche hinter sich. Sowohl der DAX als auch die großen US-Indizes gaben in der vergangenen Woche deutlich ab. Immerhin macht die Wall Street mit ihrer Performance... ► Artikel lesen | |
| HIMS & HERS HEALTH | 31,980 | +6,14 % | Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model | ||
| ECKERT & ZIEGLER | 16,000 | +3,43 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Eckert & Ziegler auf "Buy" mit einem Kursziel von 24 Euro belassen. Der Strahlen- und Medizintechnikkonzern habe durchwachsene Zahlen vorgelegt... ► Artikel lesen | |
| CENTENE | 34,025 | +7,40 % | Bernstein raises Centene stock price target to $45 on Marketplace margin recovery | ||
| ESSILORLUXOTTICA | 308,00 | -0,03 % | BARCLAYS stuft EssilorLuxottica auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für EssilorLuxottica von 345 auf 365 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktienkurse der... ► Artikel lesen |